We could not find the news article located at:
news/DNLI/globenews-2024-12-5-denali-therapeutics-announces-first-participant-dosed-in-phase-2a-study-of-lrrk2-inhibitor-biib122-in-lrrk2-associated-parkinsons-disease
Go to our news section or DNLI news section to see our available articles.
Kind regards the ChartMill team.